Log In
Thursday 22nd March 2018

New epilepsy treatment in UK

14th October 2008

A new type of treatment for epileptic patients known as Vimpat (lacosamide) has been launched in the UK.

More than 450,000 people in the UK suffer from epilepsy. Around one third continue to have seizures despite treatment. Professor Ley Sander said, "For the many patients not achieving adequate seizure control, epilepsy can have a serious affect on social, work and personal life. It is excellent news that we now have another therapeutic choice, which has been shown to be effective in a significant proportion of patients." 


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2018